文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

非典型性阿尔茨海默病(包括行为和心理症状)的系统评价

A systematic review of atypical Alzheimer's disease including behavioural and psychological symptoms.

机构信息

Department of Medicine, LKS Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Pok Fu Lam, Hong Kong.

School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.

出版信息

Psychogeriatrics. 2021 May;21(3):396-406. doi: 10.1111/psyg.12665. Epub 2021 Feb 16.


DOI:10.1111/psyg.12665
PMID:33594793
Abstract

Alzheimer's disease (AD) is the commonest cause of dementia, characterized by the clinical presentation of progressive anterograde episodic memory impairment. However, atypical presentation of patients is increasingly recognized. These atypical AD include logopenic aphasia, behavioural variant AD, posterior cortical atrophy, and corticobasal syndrome. These atypical AD are more common in patients with young onset AD before the age of 65 years old. Since medical needs (including the behavioural and psychological symptoms of dementia) of atypical AD patients could be different from typical AD patients, it is important for clinicians to be aware of these atypical forms of AD. In addition, disease modifying treatment may be available in the future. This review aims at providing an update on various important subtypes of atypical AD including behavioural and psychological symptoms.

摘要

阿尔茨海默病(AD)是痴呆最常见的病因,其特征为临床呈现出进行性顺行性情节记忆障碍。然而,越来越多的患者表现出不典型症状。这些不典型 AD 包括失语法性失语症、行为变异型 AD、后部皮质萎缩和皮质基底节综合征。这些不典型 AD 在发病年龄在 65 岁之前的早发性 AD 患者中更为常见。由于不典型 AD 患者的医疗需求(包括痴呆的行为和心理症状)可能与典型 AD 患者不同,因此临床医生了解这些不典型 AD 形式非常重要。此外,未来可能会有针对疾病的治疗方法。本综述旨在提供各种重要的不典型 AD 亚型的最新信息,包括行为和心理症状。

相似文献

[1]
A systematic review of atypical Alzheimer's disease including behavioural and psychological symptoms.

Psychogeriatrics. 2021-5

[2]
Approach to atypical Alzheimer's disease and case studies of the major subtypes.

CNS Spectr. 2017-2-15

[3]
Posterior cortical atrophy variant of Alzheimer's dementia-A case report.

Asian J Psychiatr. 2018-5-17

[4]
The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.

Dement Geriatr Cogn Disord. 2020

[5]
Focal cortical presentations of Alzheimer's disease.

Brain. 2007-10

[6]
Case Studies Illustrating Focal Alzheimer's, Fluent Aphasia, Late-Onset Memory Loss, and Rapid Dementia.

Neurol Clin. 2016-8

[7]
[Rare forms of dementia-Atypical variants of Alzheimer's dementia].

Inn Med (Heidelb). 2023-2

[8]
FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.

PLoS One. 2013-4-23

[9]
Typical and atypical appearance of early-onset Alzheimer's disease: A clinical, neuroimaging and neuropathological study.

Neuropathology. 2017-4

[10]
Neuropsychological Similarities and Differences Between Amnestic Alzheimer's Disease and its Non-Amnestic Variants.

J Alzheimers Dis. 2019

引用本文的文献

[1]
Alterations in Olfactory Cortex Volume in Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Study of Sex-Related Differences.

Brain Sci. 2025-6-4

[2]
Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer's disease using deep learning-derived saliency maps.

EJNMMI Phys. 2025-6-9

[3]
Does Dementia Have a Microbial Cause?

NeuroSci. 2022-5-17

[4]
Pathologically Confirmed Alzheimer's Disease Presenting as Clinical Parkinson's Disease, A Case Report.

Mov Disord Clin Pract. 2024-9

[5]
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.

Int J Mol Sci. 2024-9-23

[6]
A Systematic Review of the Effects of Capsaicin on Alzheimer's Disease.

Int J Mol Sci. 2023-6-15

[7]
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Health Psychol Res. 2022-1-30

[8]
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Health Psychol Res. 2022-7-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索